Clinical Trial Update: The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of lansoprazole and ecabet sodium for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Ecabet sodium (ecabet sodium)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Gastroesophageal Reflux Disease | NA | Status: COMPLETED